Imunon Inc (IMNN)
1.26
-0.05
(-3.82%)
USD |
NASDAQ |
May 01, 11:33
Imunon Cash from Operations (TTM): -19.02M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -19.02M |
September 30, 2023 | -20.26M |
June 30, 2023 | -20.43M |
March 31, 2023 | -19.21M |
December 31, 2022 | -23.10M |
September 30, 2022 | -23.18M |
June 30, 2022 | -22.32M |
March 31, 2022 | -19.46M |
December 31, 2021 | -16.22M |
September 30, 2021 | -14.87M |
June 30, 2021 | -15.04M |
March 31, 2021 | -15.38M |
December 31, 2020 | -15.62M |
September 30, 2020 | -17.50M |
June 30, 2020 | -18.02M |
March 31, 2020 | -19.70M |
December 31, 2019 | -20.26M |
September 30, 2019 | -8.556M |
June 30, 2019 | -8.342M |
March 31, 2019 | -7.922M |
December 31, 2018 | -7.042M |
September 30, 2018 | -17.34M |
June 30, 2018 | -18.18M |
March 31, 2018 | -18.17M |
December 31, 2017 | -16.64M |
Date | Value |
---|---|
September 30, 2017 | -17.10M |
June 30, 2017 | -16.71M |
March 31, 2017 | -16.77M |
December 31, 2016 | -18.38M |
September 30, 2016 | -17.62M |
June 30, 2016 | -18.21M |
March 31, 2016 | -19.64M |
December 31, 2015 | -20.83M |
September 30, 2015 | -23.44M |
June 30, 2015 | -23.96M |
March 31, 2015 | -22.47M |
December 31, 2014 | -21.35M |
September 30, 2014 | -18.31M |
June 30, 2014 | -15.13M |
March 31, 2014 | -16.14M |
December 31, 2013 | -9.525M |
September 30, 2013 | -12.04M |
June 30, 2013 | -14.63M |
March 31, 2013 | -14.63M |
December 31, 2012 | -22.14M |
September 30, 2012 | -20.61M |
June 30, 2012 | -22.26M |
March 31, 2012 | -24.10M |
December 31, 2011 | -22.74M |
September 30, 2011 | -21.07M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-23.18M
Minimum
Sep 2022
-8.342M
Maximum
Jun 2019
-17.71M
Average
-19.02M
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
Avalo Therapeutics Inc | -30.68M |
iBio Inc | -18.89M |
Ocugen Inc | -62.05M |
Petros Pharmaceuticals Inc | -7.626M |
Moderna Inc | -3.118B |